Classes
Publications
- Efficacy of erlotinib in subsequent lines of non-small cell lung cancer therapy2018 | Third Faculty of Medicine
- Differential sensitivity to apoptosome apparatus activation in non-small cell lung carcinoma and the lung2014 | First Faculty of Medicine, Third Faculty of Medicine
- Pembrolizumab: treatment in patients with axial skeletal metastases, after stabilization of the spine – case reports2023 | First Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University
- Lung Cancer in the Czech Republic2023 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Durvalumab in the treatment of locally advanced unresectable non‑small cell lung cancer – case report2023 | First Faculty of Medicine, Third Faculty of Medicine
- Treatment with pembrolizumab in a patient with non-small cell lung cancer after a faecal transplantation - case report2023 | First Faculty of Medicine, Third Faculty of Medicine
- Pharmacological profile of mepolizumab2023 | Third Faculty of Medicine
- Entrectinib and the fight against toxicities – case report2023 | Third Faculty of Medicine
- Amivantamab in non‐small cell lung cancer treatment2023 | Third Faculty of Medicine
- Nivolumab in a patient with NSCLC: a protracted but effective treatment full of toxicities - case report2023 | Third Faculty of Medicine
Loading network view...